Neuland Laboratories Executive and Leadership Team

Saharsh Davuluri, the Chief Executive Officer & Managing Director at Neuland Laboratories, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the expansion of active pharmaceutical ingredient manufacturing, Davuluri ensures alignment between technical capabilities and global regulatory requirements. This leadership role involves managing complex stakeholder relationships while driving operational efficiency across all manufacturing sites. By prioritizing innovation in process chemistry, the Chief Executive Officer & Managing Director secures the competitive position of the firm within the international pharmaceutical landscape. Saharsh Davuluri maintains a focus on sustainable growth and the acceleration of drug development cycles. Through consistent oversight of corporate governance and strategic resource allocation, the Chief Executive Officer & Managing Director fosters a culture of excellence. Ultimately, Davuluri guides the company toward achieving superior market outcomes and maintaining high standards of quality in every pharmaceutical solution provided to global partners.

Abhijit Majumdar, the Chief Financial Officer at Neuland Laboratories, directs the financial strategy and capital allocation processes for the organization. Overseeing fiscal planning, the Chief Financial Officer ensures the company maintains a robust balance sheet to support ongoing investments in pharmaceutical manufacturing infrastructure. This leadership role involves managing investor relations, financial reporting, and risk assessment to protect the long-term value of the firm. By optimizing cost structures and monitoring global market trends, Abhijit Majumdar drives financial performance and operational sustainability. The Chief Financial Officer maintains a focus on transparency and compliance with international financial regulations. Through strategic oversight of budgeting and resource management, the Chief Financial Officer supports the expansion of chemistry-related services. Abhijit Majumdar collaborates with the executive team to align financial goals with the broader corporate mission. Ultimately, the Chief Financial Officer secures the financial health necessary to sustain the company's position as a leader in the pharmaceutical sector.

Shashank Mahashabde, the Contract Manufacturing President, Business Development at Neuland Laboratories, directs the growth of the contract manufacturing division and the acquisition of new business opportunities. Overseeing the expansion of chemistry-related services, the Contract Manufacturing President, Business Development ensures that the company meets the specific needs of global pharmaceutical clients. This leadership role involves identifying new market segments and negotiating long-term partnerships for cGMP manufacturing. By leveraging the company's core competence in process chemistry, Shashank Mahashabde drives the revenue growth of the contract manufacturing segment. The Contract Manufacturing President, Business Development maintains a focus on delivering end-to-end solutions that accelerate drug development for partners. Through strategic oversight of business development initiatives, the Contract Manufacturing President, Business Development supports the company's global market reach. Mahashabde collaborates with technical teams to ensure that client requirements are met with high-quality, reliable services. Ultimately, the Contract Manufacturing President, Business Development secures the commercial pipeline necessary for sustained organizational growth.

Ajitabh Singh, the Chief Information Officer at Neuland Laboratories, directs the digital transformation and information technology infrastructure for the company. Overseeing the integration of advanced data systems, the Chief Information Officer ensures that manufacturing processes and research activities benefit from secure, scalable technology solutions. This leadership role involves managing cybersecurity protocols, enterprise resource planning, and digital connectivity across all operational sites. By implementing innovative software tools, Ajitabh Singh drives efficiency in supply chain management and regulatory documentation. The Chief Information Officer maintains a focus on leveraging data analytics to improve decision-making and operational speed. Through strategic oversight of the IT roadmap, the Chief Information Officer supports the company's commitment to high-quality pharmaceutical manufacturing. Ajitabh Singh collaborates with other executives to ensure that technological capabilities align with the evolving needs of the global pharmaceutical industry. Ultimately, the Chief Information Officer secures the digital foundation required for sustained innovation and operational excellence.

Raja Shekar, the Deputy Manager, Material Planning & Chief Marketing Officer at Neuland Laboratories, directs the strategic alignment of material procurement with market demand. Overseeing the supply chain logistics, the Chief Marketing Officer ensures that raw material availability supports the continuous production of active pharmaceutical ingredients. This leadership role involves analyzing market trends to forecast demand and optimize inventory levels for global clients. By integrating material planning with commercial outreach, Raja Shekar drives the efficiency of the manufacturing cycle. The Deputy Manager, Material Planning & Chief Marketing Officer maintains a focus on building strong relationships with pharmaceutical partners to ensure consistent service delivery. Through strategic oversight of the supply chain and marketing initiatives, the Chief Marketing Officer supports the company's reputation for reliability. Raja Shekar coordinates with production teams to ensure that market requirements are met with precision. Ultimately, the Deputy Manager, Material Planning & Chief Marketing Officer secures the operational flow necessary to maintain a competitive edge.

Hemchandra Peruvelli, the Chief Human Resources Officer at Neuland Laboratories, directs the talent acquisition, organizational development, and employee engagement strategies for the company. Overseeing the workforce planning, the Chief Human Resources Officer ensures that the organization attracts and retains top-tier scientific and technical talent. This leadership role involves fostering a culture of safety, compliance, and innovation within the regulatory environment of pharmaceutical manufacturing. By implementing comprehensive training programs, Hemchandra Peruvelli drives the professional growth of the staff. The Chief Human Resources Officer maintains a focus on aligning human capital with the strategic goals of the business. Through strategic oversight of performance management and organizational structure, the Chief Human Resources Officer supports the company's mission to provide reliable solutions to the global pharmaceutical industry. Peruvelli collaborates with the executive team to ensure that the workforce remains agile and capable of meeting complex manufacturing demands. Ultimately, the Chief Human Resources Officer secures the human capital foundation essential for long-term success.

Dr Suryanarayana, the Deputy Director at Neuland Laboratories, manages the technical scientific teams responsible for complex process chemistry and cGMP manufacturing. Overseeing the research and development pipeline, the Deputy Director ensures that all pharmaceutical solutions meet stringent regulatory standards. This leadership role involves coordinating with manufacturing units to optimize production workflows and enhance the reliability of active pharmaceutical ingredients. By applying advanced chemical engineering principles, Dr Suryanarayana drives the technical evolution of the company. The Deputy Director maintains a focus on scaling laboratory innovations into full-scale commercial production. Through rigorous oversight of scientific protocols, the Deputy Director supports the broader mission of accelerating drug development for the global pharmaceutical industry. Dr Suryanarayana facilitates cross-functional collaboration between research scientists and manufacturing engineers to ensure seamless project execution. Ultimately, the Deputy Director secures the technical integrity of the product portfolio while fostering continuous improvement in manufacturing methodologies.

Dorothy Paul, the Chief Marketing & Communications Officer at Neuland Laboratories, directs the brand positioning and external communication strategies for the organization. Overseeing the corporate messaging, the Chief Marketing & Communications Officer ensures that the company's expertise in process chemistry and cGMP manufacturing is effectively communicated to global pharmaceutical partners. This leadership role involves managing public relations, digital presence, and industry outreach to enhance the market visibility of the firm. By crafting compelling narratives around the company's 25-year history, Dorothy Paul drives brand equity and trust. The Chief Marketing & Communications Officer maintains a focus on highlighting the value of end-to-end chemistry services. Through strategic oversight of communication channels, the Chief Marketing & Communications Officer supports the business development efforts of the company. Paul collaborates with the executive team to ensure that all external messaging aligns with the core mission. Ultimately, the Chief Marketing & Communications Officer secures the company's reputation as a premier provider in the pharmaceutical industry.